30 Day Trial
ORTHOKNOW logo

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

2014 Revenue: Integra LifeSciences

4Q14 revenue: $98.1MM, flat (U.S. $83.4MM, +2%; ex-U.S. $14.7MM, -13%)

  • U.S. Extremities $40.3MM, +17%
  • U.S. Spine & Other $43.1MM, -8%

 

New product introductions (Titan Shoulder, Total Foot System 2, Freedom Wrist) + additional sales territories drove extremities hardware growth

Acquired Metasurg foot/ankle products, including distribution of BioFix amniotic-based regenerative biologic line

Spine biologics increased mid-single digits (up for 6th consecutive quarter)

Declines in spine hardware driven by price pressure, new product launch delays, slower ramp-up of new distribution

 

2014 revenue: $370.0MM, flat (U.S. $314.3MM, +1%; ex-U.S. $55.7MM, -8%)

  • U.S. Extremities $143.3MM, +12%
  • U.S. Spine & Other $171.3MM, -6%

 

SeaSpine spin-off on track to complete in 2H15

Marks 1st full year of shoulder market presence, with launch of Reverse Shoulder